Editorial: Molecular mechanisms of treatment for immune dysregulation by targeting toll-like receptors

Saved in:
Bibliographic Details
Published in:Frontiers in medicine 2024-10, Vol.11, p.1493523
Main Authors: Jo, Juandy, Garssen, Johan
Format: Article
Language:English
Subjects:
adjuvants
immunomodulation
molecular mechanism
therapeutic agents
toll-like receptor agonists
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 1493523
container_title Frontiers in medicine
container_volume 11
creator Jo, Juandy
Garssen, Johan
description
doi_str_mv 10.3389/fmed.2024.1493523
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b8805369fa8e4dc5ac8fca0f5ff7f409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_b8805369fa8e4dc5ac8fca0f5ff7f409</doaj_id><sourcerecordid>3118836510</sourcerecordid><originalsourceid>FETCH-LOGICAL-c292t-825d860b9d02790b0a8ebcb946fbe1e011cf977fa8b5f8b84ebdde8d2902e71c3</originalsourceid><addsrcrecordid>eNpNkb1uFDEUha0IRKKQB6BBLmlm45_xjE2HogCRgmiCRGf553rj4BkvtqfYt88su0GpbNnnfFe6H0IfKNlwLtV1mMBvGGH9hvaKC8bP0AVjauikkL_fvLqfo6tanwghlDPRU_4OnXPVcyIUu0Dh1seWSzTpM_6RE7glmYIncI9mjnWqOAfcCpg2wdxwyAXHaVpmwH5fC2zXdIt5xnaPmylbaHHe4pZT6lL8A7iAg92Kr-_R22BShavTeYl-fb19uPne3f_8dnfz5b5zTLHWSSa8HIhVnrBREUuMBOus6odggQKh1AU1jsFIK4K0sgfrPUjPFGEwUscv0d2R67N50rsSJ1P2Opuo_z3kstWmtOgSaCslEXxQKwx674RxMjhDgghhDD1RK-vTkbUr-e8CtekpVgcpmRnyUjWnVEo-CErWKD1GXcl13Uv4P5oSfbClD7b0wZY-2Vo7H0_4xR4-XxovbvgzAKGTiw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3118836510</pqid></control><display><type>article</type><title>Editorial: Molecular mechanisms of treatment for immune dysregulation by targeting toll-like receptors</title><source>PubMed Central</source><creator>Jo, Juandy ; Garssen, Johan</creator><creatorcontrib>Jo, Juandy ; Garssen, Johan</creatorcontrib><identifier>ISSN: 2296-858X</identifier><identifier>EISSN: 2296-858X</identifier><identifier>DOI: 10.3389/fmed.2024.1493523</identifier><identifier>PMID: 39430592</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>adjuvants ; immunomodulation ; molecular mechanism ; therapeutic agents ; toll-like receptor agonists</subject><ispartof>Frontiers in medicine, 2024-10, Vol.11, p.1493523</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39430592$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jo, Juandy</creatorcontrib><creatorcontrib>Garssen, Johan</creatorcontrib><title>Editorial: Molecular mechanisms of treatment for immune dysregulation by targeting toll-like receptors</title><title>Frontiers in medicine</title><addtitle>Front Med (Lausanne)</addtitle><subject>adjuvants</subject><subject>immunomodulation</subject><subject>molecular mechanism</subject><subject>therapeutic agents</subject><subject>toll-like receptor agonists</subject><issn>2296-858X</issn><issn>2296-858X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpNkb1uFDEUha0IRKKQB6BBLmlm45_xjE2HogCRgmiCRGf553rj4BkvtqfYt88su0GpbNnnfFe6H0IfKNlwLtV1mMBvGGH9hvaKC8bP0AVjauikkL_fvLqfo6tanwghlDPRU_4OnXPVcyIUu0Dh1seWSzTpM_6RE7glmYIncI9mjnWqOAfcCpg2wdxwyAXHaVpmwH5fC2zXdIt5xnaPmylbaHHe4pZT6lL8A7iAg92Kr-_R22BShavTeYl-fb19uPne3f_8dnfz5b5zTLHWSSa8HIhVnrBREUuMBOus6odggQKh1AU1jsFIK4K0sgfrPUjPFGEwUscv0d2R67N50rsSJ1P2Opuo_z3kstWmtOgSaCslEXxQKwx674RxMjhDgghhDD1RK-vTkbUr-e8CtekpVgcpmRnyUjWnVEo-CErWKD1GXcl13Uv4P5oSfbClD7b0wZY-2Vo7H0_4xR4-XxovbvgzAKGTiw</recordid><startdate>20241004</startdate><enddate>20241004</enddate><creator>Jo, Juandy</creator><creator>Garssen, Johan</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20241004</creationdate><title>Editorial: Molecular mechanisms of treatment for immune dysregulation by targeting toll-like receptors</title><author>Jo, Juandy ; Garssen, Johan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c292t-825d860b9d02790b0a8ebcb946fbe1e011cf977fa8b5f8b84ebdde8d2902e71c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>adjuvants</topic><topic>immunomodulation</topic><topic>molecular mechanism</topic><topic>therapeutic agents</topic><topic>toll-like receptor agonists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jo, Juandy</creatorcontrib><creatorcontrib>Garssen, Johan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jo, Juandy</au><au>Garssen, Johan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial: Molecular mechanisms of treatment for immune dysregulation by targeting toll-like receptors</atitle><jtitle>Frontiers in medicine</jtitle><addtitle>Front Med (Lausanne)</addtitle><date>2024-10-04</date><risdate>2024</risdate><volume>11</volume><spage>1493523</spage><pages>1493523-</pages><issn>2296-858X</issn><eissn>2296-858X</eissn><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>39430592</pmid><doi>10.3389/fmed.2024.1493523</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2296-858X
ispartof Frontiers in medicine, 2024-10, Vol.11, p.1493523
issn 2296-858X
2296-858X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_b8805369fa8e4dc5ac8fca0f5ff7f409
source PubMed Central
subjects adjuvants
immunomodulation
molecular mechanism
therapeutic agents
toll-like receptor agonists
title Editorial: Molecular mechanisms of treatment for immune dysregulation by targeting toll-like receptors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A18%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial:%20Molecular%20mechanisms%20of%20treatment%20for%20immune%20dysregulation%20by%20targeting%20toll-like%20receptors&rft.jtitle=Frontiers%20in%20medicine&rft.au=Jo,%20Juandy&rft.date=2024-10-04&rft.volume=11&rft.spage=1493523&rft.pages=1493523-&rft.issn=2296-858X&rft.eissn=2296-858X&rft_id=info:doi/10.3389/fmed.2024.1493523&rft_dat=%3Cproquest_doaj_%3E3118836510%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c292t-825d860b9d02790b0a8ebcb946fbe1e011cf977fa8b5f8b84ebdde8d2902e71c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3118836510&rft_id=info:pmid/39430592&rfr_iscdi=true